Skip to main content
Log in

Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in tunisia caused by multiply drug resistantSalmonella wien producing SHV-2 beta-lactamase

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

In a Tunisian hospital 27 babies, including 12 who were premature, in a single intensive care unit suffered acute gastroenteritis in the period from January to May 1988. The mean age at the onset of gastroenteritis was 8.4 days; nine babies died.Salmonella wien was isolated from stools (all babies) and blood (4 babies). It was also isolated from the stools of one nurse and from a mattress. Twelve of the babies had received cefotaxime, which was successfully replaced by oral colimycin. The outbreak was stopped by the implementation of infection control measures. All isolates ofSalmonella wien were of the same biotype, and had the same antibiotic resistance pattern (third generation cephalosporins, monobactams, aminoglycosides, chloramphenicol, trimethoprim and sulphonamides) and plasmid DNA restriction pattern. The isolates were all susceptible to a combination of cefotaxime and clavulanic acid (a β-lactamase inhibitor), which displayed synergy, suggesting the presence of a β-lactamase (geometric mean MICs 11.24 µg/ml for cefotaxime alone and 0.24 µg/ml in combination with 0.1 µg/ml potassium clavulanate). All isolates produced TEM-1 and SHV-2 β-lactamase which was not transferable toEscherichia coli by conjugation. The presence of the SHV-2 enzyme inSalmonella wien may allow it to adapt to newer β-lactams which is a cause for concern in this hospital.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Khemiri F Evaluation desSalmonella de 1977 à 1982. Archives de l'Institut Pasteur de Tunis 1983, 60: 1–2.

    PubMed  Google Scholar 

  2. Ben Hamed S, Hammami A, Turki A, Kanoun F, Ellouze F, Zribi M Etude de la sensibilité des salmonelles non typhiques isolées à Sfax (Tunisie). Médecine Tropicale 1988, 48: 237–240.

    Google Scholar 

  3. Le Minor L, Grimont PAD Origine et répartition en sérovars des souches deSalmonella isolées en France continentale au cours des années 1984 à 1987. Médecine et Maladies Infectieuses 1989, 19: 12–17.

    Article  Google Scholar 

  4. Philippon A, Fournier G, Cornel E, Paul G, Le Minor L, Névot P Les β-lactamases desSalmonella résistantes à l'ampicilline. Annales de Microbiologie 1984, 135 A: 229–238.

    Google Scholar 

  5. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J Transferable enzymatic resistance to third generation cephalosporins during nosocomial outbreak of multiresistantKlebsiella pneumoniae. Lancet 1987, ii: 302–306.

    Article  Google Scholar 

  6. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 1985, 28: 302–309.

    PubMed  Google Scholar 

  7. Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A Transferable resistance to third generation cephalosporins in clinical isolates ofKlebsiella pneumoniae: identification of CTX-1, a novel β-lactamase. Journal of Antimicrobial Chemotherapy 1987, 20: 302–307.

    Google Scholar 

  8. Ben Redjeb S, Ben Yaghlane H, Boujnah A, Philippon A, Labia R Synergy between clavulanic acid and newer β-lactams of nine clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andSalmonella typhimurium resistant to third generation cephalosporins. Journal of Antimicrobial Chemotherapy 1988, 21: 261–269.

    PubMed  Google Scholar 

  9. Carbonnelle G, Denis F, Marmonier A, Pinon G, Vargues R Bactériologie médicale, techniques usuelles. Simep, Paris, 1987.

    Google Scholar 

  10. Vieu JF, Jeanjean S, Tournier B, Klein B Application à une série unique de bactériophages à la lysotypie deSalmonella serovardublin et deSalmonella serovarenteritidis. Médecine et Maladies Infectieuses 1990, 20: 229–233.

    Article  Google Scholar 

  11. Felix A, Callow BR Paratyphoid-B Vi-phage typing. Lancet 1951, 261: 10–16.

    Article  Google Scholar 

  12. Jarlier V, Nicolas MH, Fournier G, Philippon A Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents inEnterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 1988, 10: 867–878.

    PubMed  Google Scholar 

  13. Matthew M, Harris AM, Marshall MJ, Ross GW The use of analytical isoelectric-focusing for detection and identification of β-lactamase. Journal of General Microbiology 1975, 88: 169–175.

    PubMed  Google Scholar 

  14. Takahashi S, Nagano Y Rapid procedure for isolation plasmid DNA and application to epidemiological analysis. Journal of Clinical Microbiology 1984, 20: 603–618.

    PubMed  Google Scholar 

  15. McConnell J, Smith HR, Leonardopoulos J, Anderson ES The value of plasmid studies in the epidemiology of infections due to drug-resistantSalmonella wien. Journal of Infectious Diseases 1979, 139: 178–190.

    PubMed  Google Scholar 

  16. Tauxe RV, Hassan LF, Findeisen KO, Sharrar RG, Blake PA Salmonellosis in nurses: lack of transmission to patients. Journal of Infectious Diseases 1988, 157: 370–373.

    PubMed  Google Scholar 

  17. Sanders CC, Sanders EW Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Reviews of Infectious Diseases 1983, 5: 639–648.

    PubMed  Google Scholar 

  18. Shah PM, Stille EW Escherichia coli andKlebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins. Journal of Antimicrobial Chemotherapy 1983, 11: 597–601.

    PubMed  Google Scholar 

  19. Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A Epidemiology of extended spectrum beta-lactamases. Infection 1989, 17: 347–354.

    Article  PubMed  Google Scholar 

  20. Philippon A, Labia R, Jacoby GA Extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 1989, 33: 1131–1136.

    PubMed  Google Scholar 

  21. Legrand P, Fournier G, Buré A, Jarlier V, Nicolas MH, Décré D, Duval J, Philippon A Detection and distribution of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals. European Journal of Clinical Microbiology and Infectious Diseases 1989, 8: 527–529.

    Google Scholar 

  22. Petit A, Gerbaud G, Sirot D, Courvalin P, Sirot J Molecular epidemiology of TEM-3 (CTX-1). Antimicrobial Agents and Chemotherapy 1990, 34: 219–224.

    PubMed  Google Scholar 

  23. Vuthien H, Baudon JJ, Rolland M Salmonellatyphimurium: résistance aux céphalosporines de troisième génération. Médecine et Maladies Infectieuses 1987, 6/7: 398–400.

    Article  Google Scholar 

  24. Barthélémy M, Peduzzi P, Ben Yaghlane H, Labia R Single amino acid substitution between SHV-1 and cefotaxime-hydrolyzing SHV-2 enzyme. FEBS Letters 1988, 231: 217–220.

    Article  PubMed  Google Scholar 

  25. Shaokat S, Ouellette M, Sirot D, Joly B, Cluzel R Spread of SHV-1 β-lactamase inEscherichia coli isolated from fecal samples in Africa. Antimicrobial Agents and Chemotherapy 1987, 31: 943–945.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hammami, A., Arlet, G., Ben Redjeb, S. et al. Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in tunisia caused by multiply drug resistantSalmonella wien producing SHV-2 beta-lactamase. Eur. J. Clin. Microbiol. Infect. Dis. 10, 641–646 (1991). https://doi.org/10.1007/BF01975816

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01975816

Keywords

Navigation